Literature DB >> 16710217

[Injury of inferior vena cava].

A A Baeshko, V V Klimovich, M T Voevoda, Iu N Orlovskiĭ, P V Gornostaĭ, V A Iushkevich.   

Abstract

Results of treatment of 102 patients with injuries of inferior vena cava (IVC) were analyzed. The causes of injury were penetrating stab-incised wounds of abdomen (67.5% patients), close trauma (28.2%), gunshot wounds (4.3%). Zone of confluence of iliac veins was injured in 7% patients, infrarenal and renal segments -- in 51.9%, suprarenal -- in 21.5%, supra- and retrohepatic -- in 19.6% patients. Injury of one wall of vein was revealed in 63.7% patients, both walls -- in 14.7%, complete disruption of vessel -- in 7.9%, avulsion or fissure of hepatic veins -- in 13.7%. In 96.2% patients trauma of IVC were associated with injuries of liver (37.2% cases), small intestine (26.4%), stomach (15.6%), pancreas (12.7%), duodenum (10.7%), large intestine (6.8%), and other organs (10.7%). The side suture (83.7%), circular one (5%), ligation of vein (6.2%), grafting (3.8%), and ligation of left hepatic vein (1.3%) were performed. Reconstructive surgery was carried out by general surgeon in 30% patients, and by vascular surgeon -- in 70%. Lethality was 53.9% (55 patients). Lethality after injuries of supra- and retrohepatic segments of IVC was 100%, suprarenal and renal segments -- 60.6%, infrarenal segment -- 30.6%.

Entities:  

Mesh:

Year:  2006        PMID: 16710217

Source DB:  PubMed          Journal:  Khirurgiia (Mosk)        ISSN: 0023-1207


  2 in total

1.  Reconstruction of a total avulsion of the hepatic veins and the suprahepatic inferior vena cava secondary to blunt thoracoabdominal trauma.

Authors:  Daniel Kaemmerer; Wolfgang Daffner; Martin Niwa; Thomas Kuntze; Merten Hommann
Journal:  Langenbecks Arch Surg       Date:  2010-06-04       Impact factor: 3.445

2.  Management of hemorrhage of retro hepatic inferior vena cava injury during piggy-back technique for liver transplantation.

Authors:  Aydin Unal; Yazici Pinar; Zeytunlu Murat; Kilic Murat
Journal:  Indian J Surg       Date:  2008-03-19       Impact factor: 0.656

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.